National Cancer Institute; Notice of Closed Meetings, 63666-63667 [2019-24850]

Download as PDF 63666 Federal Register / Vol. 84, No. 222 / Monday, November 18, 2019 / Notices DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Office of the Secretary; Amended Notice of Meeting Notice is hereby given of a change in the Interagency Pain Research Coordinating Committee meeting on November 18, 2019, 08:30 a.m. to 05:00 p.m., Building 35A, Porter Neuroscience Center, Room 610, 35 Convent Drive, Bethesda, MD 20892, which was published in the Federal Register on October 18, 2019, 84 FR 55974. The meeting notice is amended to change the meeting agenda from the meeting will include discussions of committee business items including information about the NIH HEAL Initiative and an update on the Pain Management Best Practices Interagency Task Force to The meeting will include discussions of committee business items including the SUPPORT act, an update on the NIH HEAL Initiative and pain initiatives outside of the NIH. The meeting is open to the public. Dated: November 12, 2019. Sylvia L. Neal, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2019–24849 Filed 11–15–19; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Cancer Institute; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Cancer Institute Special Emphasis Panel; NCI SPORE (P50) I Review. Date: January 23–24, 2020. Time: 8:00 a.m. to 4:00 p.m. Agenda: To review and evaluate grant applications. VerDate Sep<11>2014 17:41 Nov 15, 2019 Jkt 250001 Place: Hilton Washington/Rockville, 1750 Rockville Pike, Rockville, MD 20852. Contact Person: Klaus B. Piontek, Ph.D., Scientific Review Officer, Research Programs Review Branch, Division of Extramural Activities, 9609 Medical Center Drive, Room 7W116, National Cancer Institute, Rockville, MD 20892–9750, 240–276–5413, klaus.piontek@nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel; NCI SPORE (P50) II Review. Date: January 28–29, 2020. Time: 8:00 a.m. to 1:00 p.m. Agenda: To review and evaluate grant applications. Place: Hilton Washington/Rockville, 1750 Rockville Pike, Rockville, MD 20852. Contact Person: Majed M. Hamawy, Ph.D., MBA, Scientific Review Officer, Research Programs Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Dr. Rm 7W120, Bethesda, MD 20892, 240–276–6457, mh101v@nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel; NCI SPORE IV (P50) Review. Date: February 4–5, 2020. Time: 3:00 p.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: Hilton Washington/Rockville, 1750 Rockville Pike, Rockville, MD 20852. Contact Person: John Paul Cairns, Ph.D., Scientific Review Officer, Research Programs Review Branch, Division of Extramural Activities, 9609 Medical Center Drive, Room 7W244, National Cancer Institute, NIH, Bethesda, MD 20892, 240–276–5415 paul.cairns@nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel; Feasibility and Planning Studies for SPOREs to Investigate Cancer Health Disparities (P20). Date: February 7, 2020. Time: 8:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: National Cancer Institute Shady Grove, 9609 Medical Center Drive, Rm 2W910/912, Rockville, MD 20850. Contact Person: Caron A. Lyman, Ph.D., Chief, Scientific Review Officer, National Cancer Institute, NIH, Division of Extramural Activities, Research Programs Review Branch, 9609 Medical Center Dr., Rm 7W126, Bethesda, MD 20892–9750, 240–276–6348, lymanc@mail.nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel; TEP–7A: SBIR Contract Review. Date: February 11, 2020. Time: 10:30 a.m. to 5:30 p.m. Agenda: To review and evaluate contract proposals. Place: National Cancer Institute Shady Grove, 9609 Medical Center Drive, 6W030, Rockville, MD 20850 (Telephone Conference Call). Contact Person: Ivan Ding, M.D. Health Scientist Administrator, National Cancer Institute, NIH, Division of Extramural Activities, Program & Review Extramural Staff Training Office, 9609 Medical Center PO 00000 Frm 00062 Fmt 4703 Sfmt 4703 Dr., Room 7W534, Bethesda, MD 20892– 9750, 240–276–6444, dingi@mail.nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel; TEP–7B: SBIR Contract Review. Date: February 12, 2020. Time: 10:30 a.m. to 4:30 p.m. Agenda: To review and evaluate contract proposals. Place: National Cancer Institute Shady Grove, 9609 Medical Center Drive, 7W034, Rockville, MD 20850 (Telephone Conference Call). Contact Person: Ivan Ding, M.D., Health Scientist Administrator, National Cancer Institute, NIH, Division of Extramural Activities, Program & Review Extramural Staff Training Office, 9609 Medical Center Dr., Room 7W534, Bethesda, MD 20892– 9750, 240–276–6444 dingi@mail.nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel; NCI Program Project (P01) Review II. Date: February 13–14, 2020. Time: 8:00 a.m. to 4:00 p.m. Agenda: To review and evaluate grant applications. Place: Bethesda North Marriott Hotel & Conference Center, Montgomery County Conference Center Facility, 5701 Marinelli Road, North Bethesda, MD 20852. Contact Person: Mukesh Kumar, Ph.D., Scientific Review Officer, Research Program Review Branch, Division of Extramural Activities, 9609 Medical Center Drive, Room 7W618, National Cancer Institute, NIH Rockville, MD 20850, 240–276–6611 mukesh.kumar3@nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel; TEP–7C: SBIR Contract Review. Date: February 13, 2020. Time: 10:30 a.m. to 4:30 p.m. Agenda: To review and evaluate contract proposals. Place: National Cancer Institute Shady Grove, 9609 Medical Center Drive, 7W030, Rockville, MD 20850 (Telephone Conference Call). Contact Person: Ivan Ding, M.D., Health Scientist Administrator, National Cancer Institute, NIH, Division of Extramural Activities, Program & Review Extramural Staff Training Office, 9609 Medical Center Dr., Room 7W534, Bethesda, MD 20892– 9750, 240–276–6444, dingi@mail.nih.gov. Name of Committee: National Cancer Institute Initial Review Group; Subcommittee J—Career Development. Date: March 5–6, 2020. Time: 4:00 p.m. to 4:00 p.m. Agenda: To review and evaluate grant applications. Place: Bethesda Marriott Suites, 6711 Democracy Boulevard, Bethesda, MD 20817. Contact Person: Tushar Deb, Ph.D., Scientific Review Officer, Resources & Training Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W624, Rockville, MD 20850, 240– 276–6132, tushar.deb@nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention E:\FR\FM\18NON1.SGM 18NON1 Federal Register / Vol. 84, No. 222 / Monday, November 18, 2019 / Notices Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS) Dated: November 12, 2019. Melanie J. Pantoja, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2019–24850 Filed 11–15–19; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HOMELAND SECURITY Federal Emergency Management Agency The FIRM, and if applicable, the FIS report containing the final flood hazard information for each community is available for inspection at the respective Community Map Repository address listed in the tables below and will be available online through the FEMA Map Service Center at https://msc.fema.gov by the date indicated above. FOR FURTHER INFORMATION CONTACT: Rick Sacbibit, Chief, Engineering Services Branch, Federal Insurance and Mitigation Administration, FEMA, 400 C Street SW, Washington, DC 20472, (202) 646–7659, or (email) patrick.sacbibit@fema.dhs.gov; or visit the FEMA Map Information eXchange (FMIX) online at https:// www.floodmaps.fema.gov/fhm/fmx_ main.html. ADDRESSES: [Docket ID FEMA–2019–0002] Final Flood Hazard Determinations Federal Emergency Management Agency, DHS. ACTION: Notice. AGENCY: Flood hazard determinations, which may include additions or modifications of Base Flood Elevations (BFEs), base flood depths, Special Flood Hazard Area (SFHA) boundaries or zone designations, or regulatory floodways on the Flood Insurance Rate Maps (FIRMs) and where applicable, in the supporting Flood Insurance Study (FIS) reports have been made final for the communities listed in the table below. The FIRM and FIS report are the basis of the floodplain management measures SUMMARY: that a community is required either to adopt or to show evidence of having in effect in order to qualify or remain qualified for participation in the Federal Emergency Management Agency’s (FEMA’s) National Flood Insurance Program (NFIP). In addition, the FIRM and FIS report are used by insurance agents and others to calculate appropriate flood insurance premium rates for buildings and the contents of those buildings. DATES: The date of April 3, 2020 has been established for the FIRM and, where applicable, the supporting FIS report showing the new or modified flood hazard information for each community. Community 63667 The Federal Emergency Management Agency (FEMA) makes the final determinations listed below for the new or modified flood hazard information for each community listed. Notification of these changes has been published in newspapers of local circulation and 90 days have elapsed since that publication. The Deputy Associate Administrator for Insurance and Mitigation has resolved any appeals resulting from this notification. This final notice is issued in accordance with section 110 of the Flood Disaster Protection Act of 1973, 42 U.S.C. 4104, and 44 CFR part 67. FEMA has developed criteria for floodplain management in floodprone areas in accordance with 44 CFR part 60. Interested lessees and owners of real property are encouraged to review the new or revised FIRM and FIS report available at the address cited below for each community or online through the FEMA Map Service Center at https:// msc.fema.gov. The flood hazard determinations are made final in the watersheds and/or communities listed in the table below. SUPPLEMENTARY INFORMATION: (Catalog of Federal Domestic Assistance No. 97.022, ‘‘Flood Insurance.’’) Michael M. Grimm, Assistant Administrator for Risk Management, Department of Homeland Security, Federal Emergency Management Agency. Community map repository address New London County, Connecticut (All Jurisdictions) Docket No.: FEMA–B–1771 Town of North Stonington ........................................................................ Town of Stonington .................................................................................. Town of Voluntown ................................................................................... Old Town Hall, 40 Main Street, North Stonington, CT 06359. Town Hall, 152 Elm Street, Stonington, CT 06378. Town Hall, 115 Main Street, Voluntown, CT 06384. Allegany County, Maryland and Incorporated Areas Docket No.: FEMA–B–1601 and FEMA–B–1905 City of Cumberland ................................................................................... City of Frostburg ....................................................................................... Town of Barton ......................................................................................... Town of Lonaconing ................................................................................. Town of Luke ............................................................................................ Town of Midland ....................................................................................... Town of Westernport ................................................................................ Unincorporated Areas of Allegany County ............................................... City Hall, 57 North Liberty Street, Cumberland, MD 21502. City Hall, 59 East Main Street, Frostburg, MD 21532. Town Hall, 19018 Legislative Road SW, Barton, MD 21521. Town Hall, 35 East Main Street, Lonaconing, MD 21539. City Building, 510 Grant Street, Luke, MD 21540. Town Hall, 19823 Big Lane SW, Midland, MD 21532. City Building, 107 Washington Street, Westernport, MD 21562. Allegany County Office Building, 701 Kelly Road, Cumberland, MD 21502. Essex County, New Jersey (All Jurisdictions) Docket Nos.: FEMA–B–1471 and B–1800 Borough of North Caldwell ....................................................................... Borough of Roseland ................................................................................ Township of Belleville ............................................................................... Township of Bloomfield ............................................................................ VerDate Sep<11>2014 17:41 Nov 15, 2019 Jkt 250001 PO 00000 Frm 00063 Fmt 4703 Borough Hall, 141 Gould Avenue, North Caldwell, NJ 07006. Public Works Department, 300 Eagle Rock Avenue, Roseland, NJ 07068. Engineering Office, 152 Washington Avenue, Belleville, NJ 07109. Municipal Building, 1 Municipal Plaza, Bloomfield, NJ 07003. Sfmt 4703 E:\FR\FM\18NON1.SGM 18NON1

Agencies

[Federal Register Volume 84, Number 222 (Monday, November 18, 2019)]
[Notices]
[Pages 63666-63667]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-24850]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; NCI SPORE (P50) I Review.
    Date: January 23-24, 2020.
    Time: 8:00 a.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Hilton Washington/Rockville, 1750 Rockville Pike, 
Rockville, MD 20852.
    Contact Person: Klaus B. Piontek, Ph.D., Scientific Review 
Officer, Research Programs Review Branch, Division of Extramural 
Activities, 9609 Medical Center Drive, Room 7W116, National Cancer 
Institute, Rockville, MD 20892-9750, 240-276-5413, 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; NCI SPORE (P50) II Review.
    Date: January 28-29, 2020.
    Time: 8:00 a.m. to 1:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Hilton Washington/Rockville, 1750 Rockville Pike, 
Rockville, MD 20852.
    Contact Person: Majed M. Hamawy, Ph.D., MBA, Scientific Review 
Officer, Research Programs Review Branch, Division of Extramural 
Activities, National Cancer Institute, NIH, 9609 Medical Center Dr. 
Rm 7W120, Bethesda, MD 20892, 240-276-6457, [email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; NCI SPORE IV (P50) Review.
    Date: February 4-5, 2020.
    Time: 3:00 p.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Hilton Washington/Rockville, 1750 Rockville Pike, 
Rockville, MD 20852.
    Contact Person: John Paul Cairns, Ph.D., Scientific Review 
Officer, Research Programs Review Branch, Division of Extramural 
Activities, 9609 Medical Center Drive, Room 7W244, National Cancer 
Institute, NIH, Bethesda, MD 20892, 240-276-5415 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Feasibility and Planning Studies for SPOREs to Investigate 
Cancer Health Disparities (P20).
    Date: February 7, 2020.
    Time: 8:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute Shady Grove, 9609 Medical 
Center Drive, Rm 2W910/912, Rockville, MD 20850.
    Contact Person: Caron A. Lyman, Ph.D., Chief, Scientific Review 
Officer, National Cancer Institute, NIH, Division of Extramural 
Activities, Research Programs Review Branch, 9609 Medical Center 
Dr., Rm 7W126, Bethesda, MD 20892-9750, 240-276-6348, 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; TEP-7A: SBIR Contract Review.
    Date: February 11, 2020.
    Time: 10:30 a.m. to 5:30 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Cancer Institute Shady Grove, 9609 Medical 
Center Drive, 6W030, Rockville, MD 20850 (Telephone Conference 
Call).
    Contact Person: Ivan Ding, M.D. Health Scientist Administrator, 
National Cancer Institute, NIH, Division of Extramural Activities, 
Program & Review Extramural Staff Training Office, 9609 Medical 
Center Dr., Room 7W534, Bethesda, MD 20892-9750, 240-276-6444, 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; TEP-7B: SBIR Contract Review.
    Date: February 12, 2020.
    Time: 10:30 a.m. to 4:30 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Cancer Institute Shady Grove, 9609 Medical 
Center Drive, 7W034, Rockville, MD 20850 (Telephone Conference 
Call).
    Contact Person: Ivan Ding, M.D., Health Scientist Administrator, 
National Cancer Institute, NIH, Division of Extramural Activities, 
Program & Review Extramural Staff Training Office, 9609 Medical 
Center Dr., Room 7W534, Bethesda, MD 20892-9750, 240-276-6444 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; NCI Program Project (P01) Review II.
    Date: February 13-14, 2020.
    Time: 8:00 a.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Bethesda North Marriott Hotel & Conference Center, 
Montgomery County Conference Center Facility, 5701 Marinelli Road, 
North Bethesda, MD 20852.
    Contact Person: Mukesh Kumar, Ph.D., Scientific Review Officer, 
Research Program Review Branch, Division of Extramural Activities, 
9609 Medical Center Drive, Room 7W618, National Cancer Institute, 
NIH Rockville, MD 20850, 240-276-6611 [email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; TEP-7C: SBIR Contract Review.
    Date: February 13, 2020.
    Time: 10:30 a.m. to 4:30 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Cancer Institute Shady Grove, 9609 Medical 
Center Drive, 7W030, Rockville, MD 20850 (Telephone Conference 
Call).
    Contact Person: Ivan Ding, M.D., Health Scientist Administrator, 
National Cancer Institute, NIH, Division of Extramural Activities, 
Program & Review Extramural Staff Training Office, 9609 Medical 
Center Dr., Room 7W534, Bethesda, MD 20892-9750, 240-276-6444, 
[email protected].

    Name of Committee: National Cancer Institute Initial Review 
Group; Subcommittee J--Career Development.
    Date: March 5-6, 2020.
    Time: 4:00 p.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Bethesda Marriott Suites, 6711 Democracy Boulevard, 
Bethesda, MD 20817.
    Contact Person: Tushar Deb, Ph.D., Scientific Review Officer, 
Resources & Training Review Branch, Division of Extramural 
Activities, National Cancer Institute, NIH, 9609 Medical Center 
Drive, Room 7W624, Rockville, MD 20850, 240-276-6132, 
t[email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention

[[Page 63667]]

Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, 
Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, 
Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, 
Cancer Control, National Institutes of Health, HHS)

    Dated: November 12, 2019.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2019-24850 Filed 11-15-19; 8:45 am]
 BILLING CODE 4140-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.